McRae Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

McRae Capital Management’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1	Closed	-$11K	–	102
2016 Q2	$11K	Hold	1	–	–	0.01%	99
2016 Q1	$24K	Hold	1	–	–	0.01%	96
2015 Q4	$20K	Hold	1	–	–	0.01%	75
2015 Q3	$18K	Hold	1	–	–	0.01%	73
2015 Q2	$48K	Hold	1	–	–	0.02%	72
2015 Q1	$48K	Hold	1	–	–	0.02%	79
2014 Q4	$32K	Hold	1	–	–	0.01%	77
2014 Q3	$70K	Hold	1	–	–	0.03%	77
2014 Q2	$67K	Hold	1	–	–	0.03%	79
2014 Q1	$94K	Hold	1	–	–	0.05%	75
2013 Q4	$87K	Hold	1	–	–	0.04%	77
2013 Q3	$74K	Buy	+1	New	+$80.5K	0.04%	69
2013 Q2	–	Hold	0	–	–	–	65

Other funds holding YTEN

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

McRae Capital Management's YTEN Position: Q3 2016 in Review

McRae Capital Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2016, closing a stake of 1 share — an estimated $11K sold.

McRae Capital Management first reported a position in YTEN in Q3 2013 and held it in 12 quarters. The position peaked at $94K in Q1 2014. 8 funds tracked by Wall St. Rank hold YTEN as of Q3 2016.

McRae Capital Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
McRae Capital Management sold 1 Yield10 Bioscience, Inc. Common Stock share in Q3 2016, an estimated $11K.
McRae Capital Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2013 and held it in 12 quarters.
McRae Capital Management's Yield10 Bioscience, Inc. Common Stock position peaked at $94K in Q1 2014.
8 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2016.

Based on McRae Capital Management's 13F filing for Q3 2016, filed 20 Oct 2016.